These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 25533771
1. Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults. Miyashita N, Kawai Y, Inamura N, Tanaka T, Akaike H, Teranishi H, Wakabayashi T, Nakano T, Ouchi K, Okimoto N. J Infect Chemother; 2015 Mar; 21(3):153-60. PubMed ID: 25533771 [Abstract] [Full Text] [Related]
2. Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level. Inamura N, Miyashita N, Hasegawa S, Kato A, Fukuda Y, Saitoh A, Kondo E, Teranishi H, Wakabayashi T, Akaike H, Tanaka T, Ogita S, Nakano T, Terada K, Ouchi K. J Infect Chemother; 2014 Apr; 20(4):270-3. PubMed ID: 24486173 [Abstract] [Full Text] [Related]
3. Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for Mycoplasma pneumoniae pneumonia. Kawamata R, Yokoyama K, Sato M, Goto M, Nozaki Y, Takagi T, Kumagai H, Yamagata T. J Infect Chemother; 2015 Nov; 21(11):783-9. PubMed ID: 26298038 [Abstract] [Full Text] [Related]
4. Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children. Lu A, Wang C, Zhang X, Wang L, Qian L. Respir Care; 2015 Oct; 60(10):1469-75. PubMed ID: 26060318 [Abstract] [Full Text] [Related]
5. Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children. Liu TY, Lee WJ, Tsai CM, Kuo KC, Lee CH, Hsieh KS, Chang CH, Su YT, Niu CK, Yu HR. Pediatr Neonatol; 2018 Oct; 59(5):501-506. PubMed ID: 29337082 [Abstract] [Full Text] [Related]
6. Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia. Oishi T, Narita M, Matsui K, Shirai T, Matsuo M, Negishi J, Kaneko T, Tsukano S, Taguchi T, Uchiyama M. J Infect Chemother; 2011 Dec; 17(6):803-6. PubMed ID: 21681500 [Abstract] [Full Text] [Related]
7. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study. Choi YJ, Jeon JH, Oh JW. Respir Res; 2019 Aug 23; 20(1):193. PubMed ID: 31443650 [Abstract] [Full Text] [Related]
8. The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children. Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z. PLoS One; 2016 Aug 23; 11(5):e0156465. PubMed ID: 27227519 [Abstract] [Full Text] [Related]
9. [Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children]. Chen L, Liu J, Zhao S, Yang Y, Wu J. Zhonghua Er Ke Za Zhi; 2014 Mar 23; 52(3):172-6. PubMed ID: 24824385 [Abstract] [Full Text] [Related]
10. Combined treatment for child refractory Mycoplasma pneumoniae pneumonia with ciprofloxacin and glucocorticoid. Lu A, Wang L, Zhang X, Zhang M. Pediatr Pulmonol; 2011 Nov 23; 46(11):1093-7. PubMed ID: 21698787 [Abstract] [Full Text] [Related]
15. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children. Shan LS, Liu X, Kang XY, Wang F, Han XH, Shang YX. World J Pediatr; 2017 Aug 23; 13(4):321-327. PubMed ID: 28130749 [Abstract] [Full Text] [Related]